argenx
Search
  • Contact Us
US | EN US | EN
  • United States United States | English
  • CanadaCanada | English
  • CanadaCanada | Français
  • GermanyGermany | Deutsch
  • Japan:Japan: | 日本語
  • NetherlandsNetherlands | Dutch
  • SpainSpain | Español
  • United KingdomUnited Kingdom | English
  • Innovation
    Back
    How We Innovate

    Where academic discovery, clinical insights, and patient experience come together.

    Innovation Overview
    • Immunology Innovation Program
    • Our Pipeline
    • Partnered Programs
    • Clinical Trials
    • Publications
    Clinical Research

    Find information and resources to understand clinical research.

    Explore clinical research
    Case Studies

    See how we're co-creating and accelerating innovation.

    Start Exploring
  • Diseases & Patients
    Back
    Diseases and Patients

    Behind every disease we study is a person waiting for answers.

    Explore More
    • Diseases
    • Patient Voices
    • Patient Access
    • Untold Stories Podcast
    Clinical Trials

    Learn about argenx-sponsored clinical trials.

    Explore Details
    atom
    Myasthenia Gravis (MG)
    atom
    Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
    atom
    Immune Thrombocytopenia (ITP)
  • Our Products
    Back
    Our Products

    argenx’s product portfolio highlights its approved immunology therapies in the U.S.

    Explore More

    For HCPs

    • VYVGART
    • VYVGART Hytrulo

    For Patients

    • VYVGART
    • VYVGART Hytrulo
    My VYVGART® Path

    Discover resources to support you along your treatment journey today.

    Explore My VYVGART® Path
  • Who We Are
    Back
    Get to Know Us

    The people, principles, and focus behind argenx.

    argenx Overview
    • About Us
    • Our Leaders
    • Ethics & Responsibility
    Meet argenx

    One team. One culture. One focus. Watch entrepreneurial science come to life.

    Watch How We Work
    Grants

    Funding for education, initiatives, and research.

    See Our Impact
  • Newsroom
    Back
    argenx Newsroom

    Company news, media resources, and the latest from argenx.

    Explore Recent Updates
    • News & Media
    • Stories
    argenx on LinkedIn

    Get a closer look at our people and life at argenx. 

    Connect with Us
  • Investors
    Back
    Investors

    Financial information, company updates, and resources for current and prospective argenx investors.

    Explore Investors
    • Governance
    • Financials & Markets
    • Events & Presentations
    • Stock Information
    • Shareholder Meetings
    • AFM filings
    • SEC Filings
    • Analyst Coverage
    Financial Reports

    Access argenx financial reports and key updates on our performance and progress.

    View Financial Reports
  • Join Us
    Back
    Join argenx

    We’re all innovators on a continuous journey to learn, experiment, and discover on behalf of the patients we serve.

    Get to Know Us
    • The argenx Way
    • Growth & Development
    • Rewards & Recognition
    Job Openings

    See current openings.

    Explore Jobs
  • Contact Us
US | EN US | EN
  • United States United States | English
  • CanadaCanada | English
  • CanadaCanada | Français
  • GermanyGermany | Deutsch
  • Japan:Japan: | 日本語
  • NetherlandsNetherlands | Dutch
  • SpainSpain | Español
  • United KingdomUnited Kingdom | English
Search Argenx
  1. The Immunology Innovation Company | argenx
  2. Investors
  3. Events

Events

  • Share Icon X
  • Share Icon Facebook
  • Share Icon LinkedIn
  • Share Icon WhatsApp
Are you a U.S. resident?

If so, please confirm below to proceed to our U.S. product page. If not, return to our homepage.

Go Return to homepage (Global)

You are now leaving this website to visit another argenx website

Continue Cancel
You are now leaving the argenx website

This link will take you to a site maintained by a third party, which is responsible for its contents.

Ok Cancel
You are now leaving the argenx website

This link will take you to a site maintained by a third party, which is responsible for its contents.This website is intended for EU healthcare professionals only.

Ok Cancel

Subscribe

Please share just a few pieces of information so we can tailor the updates we send to you.

Please wait...

Not interested. Maybe later

Thank you for your interest!

Thank you for joining us on our journey to co-create potential therapies for people with severe autoimmune diseases. Together we discover.

Close

  • Innovation
  • Diseases & Patients
  • Our Products
  • Who We Are
  • Newsroom
  • Investors
  • Join Us
linkedIn
Instagram
youtube
Facebook

To report an adverse event or product quality issue, please email us at reportnow@argenx.com or call us at 1-833-274-9411.


©2026 argenx | Disclaimer | Privacy Policy | Regulations | U.S. Supplemental Privacy Notice

argenx registered logo
Are you a U.S. resident?

If so, please confirm below to proceed to our U.S. product page. If not, return to our homepage.

Go Return to homepage (Global)

You are now leaving this website to visit another argenx website

Continue Cancel
You are now leaving the argenx website

This link will take you to a site maintained by a third party, which is responsible for its contents.

Ok Cancel
You are now leaving the argenx website

This link will take you to a site maintained by a third party, which is responsible for its contents.This website is intended for EU healthcare professionals only.

Ok Cancel

Subscribe

Please share just a few pieces of information so we can tailor the updates we send to you.

Please wait...

Not interested. Maybe later

Thank you for your interest!

Thank you for joining us on our journey to co-create potential therapies for people with severe autoimmune diseases. Together we discover.

Close